Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit-Reference-Cited by-同舟云学术

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

Published:2023-04 Issue:4 Volume:34 Page:431-439
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Oosting S.F.,Barriuso J.,Bottomley A.,Galotti M.,Gyawali B.,Kiesewetter B.,Latino N.J.,Martinelli F.,Pe M.,Pentheroudakis G.,Roitberg F.,Vachon H.,de Vries E.G.E.,Piccart M.,Cherny N.I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference41 articles.

1. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015

2. ESMO-Magnitude of Clinical Benefit Scale version 1.1;Cherny;Ann Oncol,2017

3. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols. The SPIRIT-PRO extension;Calvert;JAMA,2018

4. Reporting of patient-reported outcomes in randomized trials. The CONSORT PRO extension;Calvert;JAMA,2013

5. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomized controlled trials: recommendations of the SISAQOL Consortium;Coens;Lancet Oncol,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial;The Lancet Oncology;2024-09

3. Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm;Blood Cancer Journal;2024-08-12

4. Effectiveness and Safety of Sublingual Fentanyl in the Treatment of Breakthrough Cancer Pain in Older Patients with Cancer: Results from a Retrospective Observational Study;Journal of Pain & Palliative Care Pharmacotherapy;2024-08-08

5. Time to Update—Requesting Inclusive Submission Categories for Oncology Research;JCO Global Oncology;2024-08